Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot study.
Chen G, Gu X, Xue J, Zhang X, Yu X, Zhang Y, Li A, Zhao Y, He G, Tang M, Xing F, Yin J, Bian X, Han Y, Cao S, Liu C, Jiang X, Zhang K, Xia Y, Li H, Niu N, Liu C; Northeastern Clinical Research Alliance of Oncology (NCRAO).
Chen G, et al. Among authors: zhang k, zhang x, zhang y.
Elife. 2023 Dec 22;12:e91737. doi: 10.7554/eLife.91737.
Elife. 2023.
PMID: 38131294
Free PMC article.
Clinical Trial.